Extracts of tea (Camellia sinensis) can reverse methicillin resistance in methicillin-resistant Staphylococcus aureus (MRSA) and also, to some extent, penicillin resistance in -lactamaseproducing S. aureus. These phenomena are explained by prevention of PBP2 synthesis and inhibition of secretion of -lactamase, respectively. Synergy between -lactams and tea extracts were demonstrated by disc diffusion, chequerboard titration and growth curves. Partition chromatography of an extract of green tea on Sephadex LH-20 yielded several fractions, one of which contained a virtually pure compound that showed the abovementioned activities, at concentrations above about 2 mg/L. The observed activities are novel and distinct from the previously reported direct antibacterial activity of tea extracts. Prevention of PBP2 synthesis offers an interesting possible new approach for the treatment of infections caused by MRSA. †Present address:
Introduction
The antimicrobial activity of tea (an aqueous extract of Camellia sinensis) was recognized 90 years ago. 1 This action is manifested both directly (as bacteriostatic and bactericidal effects) and indirectly (as inhibition of certain bacterial enzymes). 2 We report here, and explain, two further antibacterial properties of tea that occur at concentrations at least one order of magnitude lower than the bacteriostatic effect. The first of these, which we call 'activity II' (we call the previously reported direct inhibitory effect 'activity I'), was noticed as synergy with methicillin and is specific for methicillin-resistant staphylococci. The second, 'activity III', appears as synergy with benzylpenicillin against -lactamase-producing Staphylococcus aureus. We also report the purification of a compound that we believe is responsible for activities II and III.
Materials and methods

Media
Unless otherwise stated, all media were from Unipath, Basingstoke, UK.
Antibiotics
Benzylpenicillin (Crystapen), sodium methicillin and sodium flucloxacillin were from SmithKline Beecham (Betchworth, UK) and vancomycin hydrochloride was from Sigma (Poole, UK)
Bacterial strains
Methicillin-resistant S. aureus (MRSA) were from our collection of distinct strains from different countries 3 and methicillin-sensitive S. aureus (MSSA) were separate recent clinical isolates, as were two strains of bla methicillin-resistant Staphylococcus epidermidis (MRSE). Indicator strains used in bioassays (see below) were: S. aureus Oxford (bla ), S. aureus US12 (an MRSA 3 ) and S. aureus 16084 (MSSA, bla ).
Strains of other species resistant to penicillin as a result of altered penicillin-binding proteins (PBPs), pneumococci, bla gonococci and Haemophilus influenzae, were recent clinical isolates.
green tea (Japanese Sencha) for our experiments, as it is chemically simpler.
Boiling water (100 mL) was added to 2 g of dry Sencha leaves that had been pulverized in a mortar, and the mixture was filtered after standing for 10 min. The resulting clear, light green liquid was either used at once or was freeze-dried and the powder stored at 4°C in the dark. This 2% nominal extract is referred to below as extract T.
Assays of activities I, II and III
Each of the activities was measured separately by bioassay. Activity I had to be diluted out before assaying II and III; the method for assaying activity I has been described. 4 All assays were carried out in 19 cm square polystyrene plates (Nunc) containing 200 mL IsoSensitest agar, which was surface-seeded by flooding the plate and removing excess fluid after 2 min. For activity II, the indicator strain was MRSA US12 10 6 cfu/mL (1 in 50 dilution of an overnight culture), the agar contained 10 mg/L of methicillin and incubation was at 30°C. For activity III, the indicator strain was S. aureus 16084 used at 6 10 5 cfu/mL (1 in 80 dilution of an overnight culture), the agar contained benzylpenicillin at 1 mg/L, incubation was at 37°C. Wells of 8 mm diameter were filled with dilutions of extract T or its fractions, in duplicate. After overnight incubation, zones of inhibition were measured and plotted against log concentration (mg dry weight/mL). The concentration just failing to give a zone of inhibition 5 was determined by extrapolating the regression line to a zone diameter of 8 mm. Activities were sometimes expressed as a titre (mL/mg).
Isolation of active principle
Compound P, a compound showing high levels of activities II and III, but little activity I, was isolated from extract T using the chromatographic fractionation procedure previously described, 4 which was continued until 2.8 L of eluate had been obtained. Five separate peaks showing a high absorbance at 280 nm were found. Respective fractions making up these peaks were combined, assayed for activities I, II and III and evaporated to dryness.
Synergy experiments
Forty strains of MRSA, 22 with high-level methicillin resistance (MIC 256 mg/L) and 18 with low-level resistance (MIC 32-128 mg/L), and 20 strains of MSSA were tested using the chequerboard method for synergic action between extract T and methicillin. Methicillin concentrations were 1-1024 mg/L, and the tea extract was used diluted 40, 70, 100, 200 and 300 times (MIC for activity I was the 20-fold dilution). Both were incorporated into IsoSensitest agar supplemented with 2% NaCl then plates were inoculated with 10 6 cfu and incubated at 30°C for 40 h. Similar experiments were done using compound P and flucloxacillin, against 18 strains of MRSA.
Forty-nine strains of bla S. aureus (40 MRSA, nine MSSA) were tested for synergy between extract T and benzylpenicillin (0.007-512 mg/L) in a similar way, except that no NaCl supplement was added to the medium and incubation was at 37°C for 24 h.
Growth curves
The growth of MRSA alone or in the presence of various dilutions of extract T or compound P and/or methicillin or flucloxacillin was followed in flat-bottomed microtitre trays with 0.25 mL of IsoSensitest broth in each well. 6 The initial inoculum was a 1 in 50 dilution of an overnight broth culture. Plates were shaken at 100 rpm at 30°C and the OD 492 of each well was recorded at intervals with an ELISA reader (Titertek Multiskan, ICN Biomedicals, Thame, UK).
Action of crude extract on PBP synthesis
The experiments described in this and the next paragraph were kindly performed by Dr P. E. Reynolds. Two MRSA strains were used, one constitutive (13136 bla ) and one inducible (15) for PBP2 production. The former was grown overnight in broth with and without the addition of crude tea extract at 25 mg/L and the latter overnight in broth containing methicillin 100 mg/mL (as inducer), again with and without the addition of tea extract at 25 mg/L. The strains were harvested and PBPs extracted and analysed by gel electrophoresis, followed by labelling with [ 14 C]benzylpenicillin, as previously described. 7 
Action of crude extract on staphylococcal -lactamase
A bla strain of S. aureus was grown in broth containing methicillin 1 mg/L as an inducing agent, and preinduced -lactamase activity was measured in the absence and presence of 25 mg/L of tea extract, using nitrocefin. The strain was also grown in the presence of both inducing agent and of tea extract (25 mg/L), and cells and the supernatant fraction were tested separately for -lactamase activity to determine the effect of tea extract on induction and secretion.
Results
Crude extracts
Initial observations. Synergy was observed between extract T and methicillin against MRSA, and between extract T and benzylpenicillin against MSSA, by the paired hole technique, 8 at concentrations much lower than those required to show activity I (direct inhibition). 4 Extract T also showed synergy in this system with benzylpenicillin against MRSA. and was achieved at 100-and 200-fold dilutions of extract T for all but six strains. With the 300-fold dilution of extract T, all but two of the low-level resistant strains (89%), but only five of the high-level resistant strains (23%) showed synergy. Many strains were converted to methicillin sensitivity in the presence of various concentrations of extract T (Table I ). In contrast, no synergy was seen when 20 MSSA were tested against various combinations of methicillin and extract T.
Chequerboard experiments, benzylpenicillin and extract T against bla S. aureus. Synergy was found between benzylpenicillin and at least one of the concentrations of extract T tested for all strains, for which benzylpenicillin MICs ranged between 4 and 512 mg/L. Maximum synergy ranged from a FIC of 0.54 to 0.08 (mode 0.42, median 0.32) and occurred most commonly (for 65% of the strains) with 70-and 100-fold dilutions of extract T. There were no obvious differences in the behaviour of the MRSA and MSSA strains. A few strains became 'penicillin sensitive' according to the conventional criterion (MIC 0.12 mg/L; Table I ) although this required a decrease in MIC of at least seven dilution steps and, in one case (a low-level MRSA), 14 steps: the MIC of benzylpenicillin fell from 512 to 0.06 mg/L in the presence of 40-fold diluted extract T. This experiment shows the combined effect of activities II and III against the MRSA and of activity III alone against the MSSA.
Effects of extract T and methicillin or flucloxacillin on growth of MRSA.
The growth of three strains of MRSA (Den1, Fin8 and AusF) in the presence of various combinations of dilutions of extract T and methicillin or flucloxacillin was monitored. While 8 mg/L methicillin alone and 100-fold diluted extract T alone had little effect on growth patterns, the combination almost completely suppressed growth for at least 24 h, and was considerably more active than methicillin 200 mg/L. Further, flucloxacillin 4 mg/L in combination with the 200-fold dilution of extract T was much more active than flucloxacillin 64 mg/L (Figure) . In a separate experiment, viable counts carried out on strain Fin8 showed a slow bactericidal action for 100-fold diluted extract T plus methicillin 8 mg/L.
Action of extract T on PBP2 production and -lactamase production.
In the strain that produced PBP2 constitutively (S. aureus 13136, bla ), 25 mg/L of tea extract (equivalent to a dilution of c.250-fold of extract T) inhibited synthesis of PBP2 by 90% and induction of PBP2 was prevented in the inducible strain. The synthesis of PBP1 and, to some extent, PBP3 was inhibited; PBP2 was unaffected.
Extract T diluted 250-fold had little effect on the activity of preformed -lactamase. However, when it was present during the growth and induction of the enzyme, some inhibition of induction was observed, but the main effect was prevention of excretion of enzyme into the supernatant fraction. The -lactamase thus remained largely cell-bound.
Purification of extract T and activity of compound P
Five fractions obtained by partition chromatography of extract T were assayed for activities I, II and III. Activity I was clearly separated from activities II and III; the former was most concentrated in fraction B, while the two latter were found in fraction D (Table II) . Further, activity I was present in similar amounts in three of the fractions (suggesting involvement of more than one molecular species), a pattern that contrasted with that of activities II and III (which could not be separated). Compound P was obtained virtually pure by evaporation of fraction D; it showed activity II against ten strains of MRSA at concentrations between 1 and 3 mg/L, and against two strains of MRSE. In a chequerboard experiment, compound P showed synergy with flucloxacillin against all 18 strains of MRSA tested (median value of minimum FIC was 0.19). Synergy was also clearly demonstrated by growth curves for four MRSA strains: the combination of flucloxacillin 4 mg/L compound P 20 mg/L was considerably more inhibitory than flucloxacillin 64 mg/L (Figure) .
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Discussion
The antimicrobial principles (activity I) of extract T differ from those reported 9 for the essential oil of the 'tea tree' (Melaleuca alterniflora). The latter has no botanical or chemical relationship to C. sinensis. Essential oils are virtually insoluble in water, unlike the principles responsible for activity I of extract T which are highly soluble. C. sinensis also has essential oils (volatile flavour compounds), of which nerolidol has the greatest activity I potency, 10 about 100-fold greater than that of 'tea tree' oil. Previous work 2, 4 suggests that activity I in tea is a property of several low molecular weight ( 450) catechins, based on the isoflanavol structure, together with dimers known as theaflavins. Compounds of the latter type are absent from green tea. This is consistent with our finding here that activity I was spread over several fractions, suggesting the involvement of different molecular species. It has been suggested 11 that catechins kill bacteria by disrupting their membranes.
Contrary to popular belief, tea extracts do not contain tannin, 12 a toxic, high molecular weight compound. Activity II is highly selective, affecting only staphylococci that make PBP2 . Other variations of 'normal' PBPs that can confer penicillin resistance on species such as pneumococci, gonococci and H. influenzae were not susceptible to activity II. Activities I and II were clearly separable. Activity II is more potent than activity I, as the former could still be detected in 300-fold diluted extract T (about 20 mg/L) in the synergy, PBP and growth curve experiments, while activity I disappeared when extract T was diluted more than 20-fold (c.300 mg/L). Compound P, the active principle of extract T, showed activity down to about 2 mg/L. Our experiments suggest that activities II and III may reside in the same molecule. Activity III clearly differs from suicide inhibitors such as clavulanate, as extract T did not inhibit the action of preformed staphylococcal -lactamase. Extract T did not inhibit induction; rather, its target was the excretion of -lactamase from the cell. The amount of synergy produced between extract T and benzylpenicillin shows that this has a profound effect on staphylococcal susceptibility.
It is not surprising that interference with the production of PBP2 (e.g. activity II) should also have some effect on -lactamase activity (e.g. activity III), as mecA shares the same induction system as -lactamase. It has been suggested that mecA arose by fusion of the -lactamase regulatory region with a structural gene specifying a PBP with low affinity for -lactams (see review 13 ). The ability of activity II to prevent MRSA making PBP2 is a potentially important weapon against resistance. Thus, compound P, the component of extract T with activity II, should act as a molecular chaperone of the type envisaged by Levy (see reference 14) . Activity II alone is not harmful to staphylococci, whether or not they are methicillin-resistant, so it would not exert any selection pressure. However, in the presence of a -lactam antibiotic it renders MRSA sensitive.
Other compounds that mimic activity II in extract T have been described in the literature. Two non-ionic detergents, Triton X-100 (t-octylphenoxypolyethoxyethanol) 15 and Polidocanol (dodecylpolyethyleneoxide ether), 16 seem to reduce methicillin resistance in MRSA by involving autolytic enzymes rather than PBPs. The complex polyoxytungstates created when sodium tungstate and disodium hydrogen phosphate solutions are mixed and heated 17 depress the formation of PBP2 . A tripeptide composed of carbobenzoxy-diphenylalanine-proline-phenylalanine alcohol (LY 301621) acts, in four of its eight possible configurations, synergically with methicillin, 18 but the mechanism of synergy has not been investigated. Microcide Pharmaceuticals 19 have reported a series of synthetic compounds loosely based on a decalin nucleus (saturated naphthalene) that appeared to show activities analogous to activity II and III reported here for extract T. No chemicals of similar structure to this occur in tea. 20 Little information is available on compounds in this series, and their toxicity is unknown. Tea, on the other hand, is a self-renewable resource, and the beverage has been drunk (c. 5 10 8 L/day at present 21 ) for hundreds of years by billions of people without any harmful effectsrather the reverse in fact. 22 
